Introduction: We aimed to develop and validate an Expanded Disability Status Scale (EDSS) model through clinical, optical coherence tomography (OCT), and magnetic resonance imaging (MRI) measures. Methods: Sixty-four multiple sclerosis (MS) patients underwent peripapillary retinal nerve fiber layer and segmented macular layers evaluation through OCT (Spectralis, Heidelberg Engineering). Brain parenchymal fraction was quantified through Freesurfer, while cervical spinal cord (SC) volume was assessed manually guided by Spinal Cord Toolbox software analysis. EDSS, neuroradiological, and OCT assessment were carried out within 3 months. OCT parameters were calculated as the average of both nonoptic neuritis (ON) eyes, and in case the patient had previous ON, the value of the fellow non-ON eye was taken. Brain lesion volume, sex, age, disease duration, and history of disease-modifying treatment (1st or 2nd line disease-modifying treatments) were tested as covariables of the EDSS score. Results: EDSS values correlated with patient’s age (r = 0.543, p = 0.001), SC volume (r = −0.301, p = 0.034), and ganglion cell layer (GCL, r = −0.354, p = 0.012). Using these correlations, an ordinal regression model to express probability of diverse EDSS scores were designed, the highest of which was the most probable (Nagelkerke R2 = 43.3%). Using EDSS cutoff point of 4.0 in a dichotomous model, compared to a cutoff of 2.0, permits the inclusion of GCL as a disability predictor, in addition to age and SC. Conclusions: MS disability measured through EDSS is an age-dependent magnitude that is partly conditioned by SC and GCL. Further studies assessing paraclinical disability predictors are needed.

1.
Kurtzke
JF
.
A new scale for evaluating disability in multiple sclerosis
.
Neurology
.
1955 Aug
;
5
(
8
):
580
3
. .
2.
Kurtzke
JF
.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
.
Neurology
.
1983 Nov
;
33
(
11
):
1444
52
. .
3.
Meyer-Moock
S
,
Feng
YS
,
Maeurer
M
,
Dippel
FW
,
Kohlmann
T
.
Systematic literature review and validity evaluation of the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis
.
BMC Neurol
.
2014 Mar
;
14
:
58
. .
4.
Housley
WJ
,
Pitt
D
,
Hafler
DA
.
Biomarkers in multiple sclerosis
.
Clin Immunol
.
2015 Nov
;
161
(
1
):
51
8
. .
5.
Comabella
M
,
Sastre-Garriga
J
,
Montalban
X
.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response
.
Curr Opin Neurol
.
2016 Jun
;
29
(
3
):
254
62
. .
6.
Costello
F
,
Burton
JM
.
Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?
Eye Brain
.
2018 Jul 31
;
10
:
47
63
. .
7.
Rothman
A
,
Murphy
OC
,
Fitzgerald
KC
,
Button
J
,
Gordon-Lipkin
E
,
Ratchford
JN
,
Retinal measurements predict 10-year disability in multiple sclerosis
.
Ann Clin Transl Neurol
.
2019 Jan 19
;
6
(
2
):
222
32
. .
8.
Martínez-Lapiscina
EH
,
Fraga-Pumar
E
,
Gabilondo
I
,
Martínez-Heras
E
,
Torres-Torres
R
,
Ortiz-Pérez
S
,
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
.
BMC Res Notes
.
2014 Dec 15
;
7
:
910
. .
9.
Gabilondo
I
,
Martínez-Lapiscina
EH
,
Martínez-Heras
E
,
Fraga-Pumar
E
,
Llufriu
S
,
Ortiz
S
,
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis
.
Ann Neurol
.
2014 Jan
;
75
(
1
):
98
107
. .
10.
Kotelnikova
E
,
Kiani
NA
,
Abad
E
,
Martinez-Lapiscina
EH
,
Andorra
M
,
Zubizarreta
I
,
Dynamics and heterogeneity of brain damage in multiple sclerosis
.
PLoS Comput Biol
.
2017 Oct 26
;
13
(
10
):
e1005757
. .
11.
Optic Neuritis Study Group
.
Visual function 15 years after optic neuritis: a final follow-up report from the optic neuritis treatment trial
.
Ophthalmology
.
2008 Jun
;
115
(
6
):
1079
e5
. .
12.
Brandt
AU
,
Specovius
S
,
Oberwahrenbrock
T
,
Zimmermann
HG
,
Paul
F
,
Costello
F
.
Frequent retinal ganglion cell damage after acute optic neuritis
.
Mult Scler Relat Disord
.
2018 May
;
22
:
141
7
. .
13.
Nolan-Kenney
R
,
Liu
M
,
Akhand
O
,
Calabresi
PA
,
Paul
F
,
Petzold
A
,
Optimal intereye differences thresholds by optical coherence tomography in multiple sclerosis: an international study
.
Ann Neurol
.
2019 May
;
85
(
5
):
618
29
. .
14.
Sanchez-Dalmau
B
,
Martínez-Lapiscina
EH
,
Pulido-Valdeolivas
I
,
Zubizarreta
I
,
Llufriu
S
,
Blanco
Y
,
Predictors of vision impairment in multiple sclerosis
.
PLoS One
.
2018 Apr 17
;
13
(
4
):
e0195856
. .
15.
Tewarie
P
,
Balk
L
,
Costello
F
,
Green
A
,
Martin
R
,
Schippling
S
,
The OSCAR-IB consensus criteria for retinal OCT quality assessment
.
PLoS One
.
2012
;
7
(
4
):
e34823
. .
16.
Schippling
S
,
Balk
LJ
,
Costello
F
,
Albrecht
P
,
Balcer
L
,
Calabresi
PA
,
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
.
Mult Scler
.
2015 Feb
;
21
(
2
):
163
70
. .
17.
Cohen
AB
,
Neema
M
,
Arora
A
,
Dell'oglio
E
,
Benedict
RH
,
Tauhid
S
,
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis
.
J Neuroimaging
.
2012 Apr
;
22
(
2
):
122
8
. .
18.
Weinshenker
BG
,
Rice
GP
,
Noseworthy
JH
,
Carriere
W
,
Baskerville
J
,
Ebers
GC
.
The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials
.
Brain
.
1991 Apr
;
114
(
Pt 2
):
1057
67
. .
19.
Miller
DH
,
Hornabrook
RW
,
Purdie
G
.
The natural history of multiple sclerosis: a regional study with some longitudinal data
.
J Neurol Neurosurg Psychiatry
.
1992 May
;
55
(
5
):
341
6
. .
20.
Cutter
GR
,
Baier
ML
,
Rudick
RA
,
Cookfair
DL
,
Fischer
JS
,
Petkau
J
,
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
.
Brain
.
1999 May
;
122
(
Pt 5
):
871
82
. .
21.
Fisher
JS
,
Rudick
RA
,
Cutter
GR
,
Reingold
SC
.
The multiple sclerosis functional composite measure (MSFC): an integrate approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force
.
Mult Scler
.
1999 Aug
;
5
(
4
):
244
50
. .
22.
Confavreux
C
,
Vukusic
S
.
The clinical course of multiple sclerosis
.
Handb Clin Neurol
.
2014
;
122
:
343
69
. .
23.
Tomassini
V
,
Fanelli
F
,
Prosperini
L
,
Cerqua
R
,
Cavalla
P
,
Pozzilli
C
.
Predicting the profile of increasing disability in multiple sclerosis
.
Mult Scler
.
2019 Aug
;
25
(
9
):
1306
15
. .
24.
Oh
J
,
Sotirchos
ES
,
Saidha
S
,
Whetstone
A
,
Chen
M
,
Newsome
SD
,
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis
.
Neurology
.
2015 Feb 17
;
84
(
7
):
720
8
. .
25.
Dekker
I
,
Eijlers
AJC
,
Popescu
V
,
Balk
LJ
,
Vrenken
H
,
Wattjes
MP
,
Predicting clinical progression in multiple sclerosis after 6 and 12 years
.
Eur J Neurol
.
2019 Jun
;
26
(
6
):
893
902
. .
26.
Charalambous
T
,
Tur
C
,
Prados
F
,
Kanber
B
,
Chard
DT
,
Ourselin
S
,
Structural network disruption markers explain disability in multiple sclerosis
.
J Neurol Neurosurg Psychiatry
.
2019 Feb
;
90
(
2
):
219
26
. .
27.
Swanton
JK
,
Fernando
KT
,
Dalton
CM
,
Miszkiel
KA
,
Altmann
DR
,
Plant
GT
,
Early MRI in optic neuritis: the risk for disability
.
Neurology
.
2009 Feb 10
;
72
(
6
):
542
50
. .
28.
Lukas
C
,
Knol
DL
,
Sombekke
MH
,
Bellenberg
B
,
Hahn
HK
,
Popescu
V
,
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis
.
J Neurol Neurosurg Psychiatry
.
2015 Apr
;
86
(
4
):
410
8
. .
29.
Daams
M
,
Weiler
F
,
Steenwijk
MD
,
Hahn
HK
,
Geurts
JJ
,
Vrenken
H
,
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability
.
Mult Scler
.
2014 Dec
;
20
(
14
):
1860
5
. .
30.
Bernitsas
E
,
Bao
F
,
Seraji-Bozorgzad
N
,
Chorostecki
J
,
Santiago
C
,
Tselis
A
,
Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes
.
Mult Scler Relat Disord
.
2015 Jan
;
4
(
1
):
47
51
. .
31.
Furby
J
,
Hayton
T
,
Altmann
D
,
Brenner
R
,
Chataway
J
,
Smith
KJ
,
A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis
.
J Neurol
.
2010 Sep
;
257
(
9
):
1508
16
. .
32.
Ruggieri
S
,
Petracca
M
,
Miller
A
,
Krieger
S
,
Ghassemi
R
,
Bencosme
Y
,
Association of deep gray matter damage with cortical and spinal cord degeneration in primary progressive multiple sclerosis
.
JAMA Neurol
.
2015 Dec
;
72
(
12
):
1466
74
. .
33.
Kolind
S
,
Seddigh
A
,
Combes
A
,
Russell-Schulz
B
,
Tam
R
,
Yogendrakumar
V
,
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker
.
Neuroimage Clin
.
2015 Oct 3
;
9
:
574
80
. .
34.
Liptak
Z
,
Berger
AM
,
Sampat
MP
,
Charil
A
,
Felsovalyi
O
,
Healy
BC
,
Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis
.
AJNR Am J Neuroradiol
.
2008 Sep
;
29
(
8
):
1465
70
. .
35.
Noseworthy
JH
,
Vandervoot
MK
,
Wong
CJ
,
Ebers
GC
.
Interrater variability with the expanded disability status scale (EDSS) and functional system (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group
.
Neurology
.
1990 Jun
;
40
(
6
):
971
5
. .
36.
Goodkin
DE
,
Cookfair
D
,
Wende
K
,
Bourdette
D
,
Pullicino
P
,
Scherokman
B
,
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kutzke expanded disability status scale (EDSS)
.
Neurology
.
1992 Apr
;
42
(
4
):
859
63
. .
37.
Liu
Y
,
Wang
J
,
Daams
M
,
Weiler
F
,
Hahn
HK
,
Duan
Y
,
Differential patterns of spinal cord and brain atrophy in NMO and MS
.
Neurology
.
2015 Apr 7
;
84
(
14
):
1465
72
. .
38.
Furby
J
,
Hayton
T
,
Anderson
V
,
Altmann
D
,
Brenner
R
,
Chataway
J
,
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis
.
Mult Scler
.
2008 Sep
;
14
(
8
):
1068
75
. .
39.
Zivadinov
R
,
Banas
AC
,
Yella
V
,
Abdelrahman
N
,
Weinstock-Guttman
B
,
Dwyer
MG
.
Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis
.
AJNR Am J Neuroradiol
.
2008 Feb
;
29
(
2
):
319
25
. .
40.
Bonati
U
,
Fisniku
LK
,
Altmann
DR
,
Yiannakas
MC
,
Furby
J
,
Thompson
AJ
,
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability
.
J Neurol Neurosurg Psychiatry
.
2011 Apr
;
82
(
4
):
471
2
. .
41.
Agosta
F
,
Absinta
M
,
Sormani
MP
,
Ghezzi
A
,
Bertolotto
A
,
Montanari
E
,
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
.
Brain
.
2007 Aug
;
130
(
Pt 8
):
2211
9
. .
42.
Tsagkas
C
,
Magon
S
,
Gaetano
L
,
Pezold
S
,
Naegelin
Y
,
Amann
M
,
Spinal cord volume loss: a marker of disease progression in multiple sclerosis
.
Neurology
.
2018 Jul 24
;
91
(
4
):
e349
58
. .
43.
Kearney
H
,
Altmann
DR
,
Samson
RS
,
Yiannakas
MC
,
Wheeler-Kingshott
CA
,
Ciccarelli
O
,
Cervical cord lesion load is associated with disability independently from atrophy in MS
.
Neurology
.
2015 Jan 27
;
84
(
4
):
367
73
. .
44.
Lukas
C
,
Sombekke
MH
,
Bellenberg
B
,
Hahn
HK
,
Popescu
V
,
Bendfeldt
K
,
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients
.
Radiology
.
2013 Nov
;
269
(
2
):
542
52
. .
45.
Schlaeger
R
,
Papinutto
N
,
Zhu
AH
,
Lobach
IV
,
Bevan
CJ
,
Bucci
M
,
Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis
.
JAMA Neurol
.
2015 Aug
;
72
(
8
):
897
904
. .
46.
Saidha
S
,
Syc
SB
,
Durbin
MK
,
Eckstein
C
,
Oakley
JD
,
Meyer
SA
,
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness
.
Mult Scler
.
2011 Dec
;
17
(
12
):
1449
63
. .
47.
Aboulenein-Djamshidian
F
,
Krššák
M
,
Serbecic
N
,
Rauschka
H
,
Beutelspacher
S
,
Kukurová
IJ
,
CROP – the clinico-radiologico-ophthalmological paradox in multiple sclerosis: are patterns of retinal and MRI changes heterogeneous and thus not predictable?
PLoS One
.
2015 Nov 13
;
10
(
11
):
e0142272
. .
48.
Bellenberg
B
,
Busch
M
,
Trampe
N
,
Gold
R
,
Chan
A
,
Lukas
C
.
1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis
.
Eur Radiol
.
2013 Dec
;
23
(
12
):
3379
92
. .
49.
Brownlee
WJ
,
Altmann
DR
,
Alves Da Mota
P
,
Swanton
JK
,
Miszkiel
KA
,
Wheeler-Kingshott
CG
,
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
.
Mult Scler
.
2017 Apr
;
23
(
5
):
665
74
. .
50.
Nakamura
Y
,
Liu
Z
,
Fukumoto
S
,
Shinoda
K
,
Sakoda
A
,
Matsushita
T
,
Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder
.
Eur J Neurol
.
2020 Jan
;
27
(
1
):
92
9
. .
51.
Oh
J
,
Zackowski
K
,
Chen
M
,
Newsome
S
,
Saidha
S
,
Smith
SA
,
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis
.
Mult Scler
.
2013 Apr
;
19
(
4
):
427
35
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.